Developer docs
API playgroundTry for free, no card

Search company profiles

LaunchWorks

Full company profile

uuid000mos4

Namestring
LaunchWorks
Legal namestring
LaunchWorks, LLC
Company typeenum
Private
Founded yearint
2010
Descriptiontext

LaunchWorks CDMO is a contract development and manufacturing organization (CDMO) specializing in molecular diagnostics and life science products, operating as a wholly-owned subsidiary of Integreon Global since its acquisition in 2017-2019. The company operates from a 30,000 ft2 ISO-13485:2016 and FDA-registered facility in Beverly, Massachusetts (established 2011-2012) and an MDEL-licensed clean room in Anjou, Quebec (established 2020 in partnership with Cryopak Canada), with engineering and microfluidic device R&D conducted through a Montreal-based collaboration with the National Research Council of Canada called the Laboratory of Industrial Fluidic Translation (LIFT). LaunchWorks is ISO-13485:2016 certified, FDA registered, and cGMP compliant, serving as a regulated manufacturing partner for RUO, POC, and IVD product developers.

The company's service portfolio is organized around a proprietary five-phase Product Manufacturing Plan covering design and development (including pilot lot production, lyophilization formulation, assay refinement, and stability testing), technology transfer and onboarding, precision manufacturing (formulation, automated and manual filling, custom labeling, kit assembly), product launch and fulfillment (including temperature-controlled storage at +4°C, -20°C, and -80°C, and cold-chain logistics via Mercury Logistics), and post-launch efficiency programs. Core product types manufactured include dry chemistry sample collection kits, complex NGS kits containing hundreds of oligonucleotides, and custom enzyme purification services. The QC testing stack includes library prep and quantification, enzyme activity assays, qPCR/PCR, gel electrophoresis, cell counting, oligo quantification, BL2 lab services, and contaminant testing.

Revenue is generated through project-based professional services contracts with quote-based (non-publicly-disclosed) pricing, governed by a Terms and Conditions document dated June 2023. Customers are primarily startup innovators without manufacturing infrastructure, high-volume dry kitting organizations, and diagnostic product companies at design freeze, each supported by a dedicated project manager through a consultative enterprise field sales motion. The company employs 11-50 staff and does not publicly disclose revenue, funding, or customer counts. Distribution is direct, supplemented by a web-based customer fulfillment portal for ordering, inventory, and shipment tracking.

Short descriptiontext

LaunchWorks CDMO is an ISO-13485:2016 certified, FDA-registered contract development and manufacturing organization specializing in molecular diagnostics. It serves diagnostic startups and commercial-scale life science companies with design, formulation, fill/finish, lyophilization, and cold-chain fulfillment services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBeverly, United States
HQ citystring
Beverly
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract manufacturing services, molecular diagnostics manufacturing, life sciences CDMO, lyophilization services, diagnostic kit assembly
Industry1 code
1Lyophilization (Freeze-Drying) CDMO
CodeHLAGABAIPrimaryYes
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Contract Manufacturing (CDMO for Molecular Diagnostics)
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Manufacturing Services
TypeProfessional Services
Description

Full-service CDMO providing molecular diagnostics manufacturing including formulation, filling, labeling, kit assembly, and quality control testing under cGMP and ISO 13485 standards. Revenue generated through project-based contracts with dedicated project management.

launchworkscdmo.com
2Design and Development Services
TypeProfessional Services
Description

Product development services including raw material optimization, guard banding studies, pilot lot builds, final package and label design, and stability studies. Provided as part of the CDMO service offering.

launchworkscdmo.com
3Fulfillment and Storage Services
TypeProfessional Services
Description

Order management, inventory management, kitting services, product tracking, carrier logistics, and temperature-controlled storage (+4°C, -20°C, -80°C) for finished diagnostic products.

launchworkscdmo.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

LaunchWorks CDMO provides full-service contract development and manufacturing for molecular diagnostics and life science products, spanning design and development, technology transfer, cGMP/ISO-13485 manufacturing (formulation, automated and manual filling, lyophilization, kit assembly, labeling), quality control testing, and temperature-controlled fulfillment and storage. Its offerings are organized around a proprietary five-phase Product Manufacturing Plan that takes RUO, POC, and IVD products from pilot lot through commercial launch and post-launch optimization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced time to market through integrated design, development, and manufacturing services
+2 more records
Product overview1 text field

LaunchWorks CDMO is a full-service Contract Development and Manufacturing Organization (CDMO) specializing in molecular diagnostics manufacturing. The company offers an integrated suite of services organized around its proprietary five-stage Product Manufacturing Plan: Design & Development (including lyophilization, stability testing, and QC specification development), Technology Transfer & Onboarding, Precision Manufacturing (formulation, filling, labeling, kitting), Product Launch & Fulfillment (including cold-chain logistics and storage), and Post-Launch Efficiencies. Key product types include dry chemistry sample collection kits, complex NGS kits containing hundreds of oligonucleotides, and custom enzyme purification services. The company is ISO-13485:2016 certified and FDA registered, serving startup innovators through high-volume commercial manufacturers in the RUO, POC, and IVD segments.

Product and service1 record
1Design & Development Services
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeOthersAnnounced on2019-01-01
Description

Integreon Global acquired LaunchWorks in 2017. The parent company provides business relationships for lyophilization, precision plastic molding, and cold chain packing solutions. LaunchWorks rebranded from LaunchWorks Manufacturing Lab to LaunchWorks CDMO as part of the Integreon Global family of companies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

LaunchWorks Manufacturing Lab and Cryopak Canada collaborated with NRC to create LIFT (Laboratory of Industrial Fluidic Translation). Cryopak provides cold chain packaging solutions and together they established an MDEL licensed clean room lab facility in Montreal for CDMO projects.

3Laboratory of Industrial Fluidic Translation (LIFT)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Joint collaboration between LaunchWorks, Cryopak Canada, and NRC to offer competitive capacity for microfluidic bio-device development. Design and development done at NRC in Montréal with manufacturing at LaunchWorks Beverly facility and future plans for additional manufacturing at Cryopak Canada.

launchworkscdmo.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NRC partners with Canadian industry to take research impacts from the lab to the marketplace. The NRC-LIFT collaboration combines NRC's expertise in nanofabrication and lab-on-a-chip technologies with LaunchWorks' cGMP and ISO 13485 manufacturing capabilities at clinical and industrial scale to accelerate creation, certification and deployment of microfluidic bio-devices.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official LaunchWorks logistics partner specializing in time and temperature sensitive supply chain management. Creates customized shipping solutions and proactively tracks every package to ensure products reach destinations safely.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global biotechnology CDMO offering gene synthesis, protein production, and custom reagent manufacturing with diagnostics industry focus. Comparable service portfolio including custom oligonucleotides, peptide synthesis, and diagnostic kit assembly.

TypeDirect peer
Description

Contract development and manufacturing organization offering integrated services from drug discovery through commercial manufacturing. Similar CDMO business model to LaunchWorks, with comparable services in formulation, filling, and analytical testing, though broader therapeutic focus.

TypeBroad incumbent
Description

Major life sciences and diagnostics company with significant molecular diagnostics manufacturing capabilities, including digital PCR and qPCR products. Broader portfolio and global footprint than LaunchWorks, but overlapping customer base in IVD kit manufacturing and contract services.

TypeDirect peer
Description

Diagnostics-focused manufacturer of IVD test kits and reagents, including molecular diagnostics. Now part of Revvity/Sumitomo. Directly comparable to LaunchWorks in serving the molecular diagnostics manufacturing market with similar customer profiles of diagnostic developers and clinical labs.

TypeDirect peer
Description

Manufacturer of reagents and diagnostic test kits for life sciences research and clinical diagnostics. Similar focus on molecular biology reagents, qPCR, and protein analysis. Overlapping customer segments of academic, biotech, and diagnostic companies requiring specialized reagent manufacturing.

TypeDirect peer
Description

CDMO specializing in cell culture media, diagnostics reagents, and life sciences manufacturing. Comparable in serving diagnostic and biotech customers with custom manufacturing services, though focused on cell-based applications rather than purely molecular diagnostics.

TypeBroad incumbent
Description

Part of Eurofins Scientific network, offering genomics services and custom oligo/kit manufacturing. Direct overlap in custom NGS kit manufacturing and oligonucleotide services. Significantly larger scale and broader geographic footprint than LaunchWorks.

TypeDirect peer
Description

CDMO specializing in nucleic acids, proteins, and biological components for diagnostic and therapeutic applications. Now part of Danaher. Direct peer in serving molecular diagnostics customers with custom manufacturing of complex biological reagents, similar to LaunchWorks' NGS kit and enzyme purification services.

TypeBroad incumbent
Description

Global leader in life sciences with substantial CDMO capabilities through its Pharma Services division. Direct overlap in diagnostic kit manufacturing, custom reagent production, and analytical services. Significantly larger scale and resources than LaunchWorks.

TypeBroad incumbent
Description

Life sciences measurement and testing company with diagnostics manufacturing capabilities through SeraCare (now LGC Clinical Diagnostics). Provides reference materials, controls, and custom IVD manufacturing comparable to LaunchWorks' QC testing and diagnostic kit production services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LaunchWorks

Contract Manufacturing (CDMO for Molecular Diagnostics)launchworkscdmo.com

LaunchWorks CDMO is an ISO-13485:2016 certified, FDA-registered contract development and manufacturing organization specializing in molecular diagnostics. It serves diagnostic startups and commercial-scale life science companies with design, formulation, fill/finish, lyophilization, and cold-chain fulfillment services.

What LaunchWorks does

LaunchWorks CDMO is a contract development and manufacturing organization (CDMO) specializing in molecular diagnostics and life science products, operating as a wholly-owned subsidiary of Integreon Global since its acquisition in 2017-2019. The company operates from a 30,000 ft2 ISO-13485:2016 and FDA-registered facility in Beverly, Massachusetts (established 2011-2012) and an MDEL-licensed clean room in Anjou, Quebec (established 2020 in partnership with Cryopak Canada), with engineering and microfluidic device R&D conducted through a Montreal-based collaboration with the National Research Council of Canada called the Laboratory of Industrial Fluidic Translation (LIFT). LaunchWorks is ISO-13485:2016 certified, FDA registered, and cGMP compliant, serving as a regulated manufacturing partner for RUO, POC, and IVD product developers.

The company's service portfolio is organized around a proprietary five-phase Product Manufacturing Plan covering design and development (including pilot lot production, lyophilization formulation, assay refinement, and stability testing), technology transfer and onboarding, precision manufacturing (formulation, automated and manual filling, custom labeling, kit assembly), product launch and fulfillment (including temperature-controlled storage at +4°C, -20°C, and -80°C, and cold-chain logistics via Mercury Logistics), and post-launch efficiency programs. Core product types manufactured include dry chemistry sample collection kits, complex NGS kits containing hundreds of oligonucleotides, and custom enzyme purification services. The QC testing stack includes library prep and quantification, enzyme activity assays, qPCR/PCR, gel electrophoresis, cell counting, oligo quantification, BL2 lab services, and contaminant testing.

Revenue is generated through project-based professional services contracts with quote-based (non-publicly-disclosed) pricing, governed by a Terms and Conditions document dated June 2023. Customers are primarily startup innovators without manufacturing infrastructure, high-volume dry kitting organizations, and diagnostic product companies at design freeze, each supported by a dedicated project manager through a consultative enterprise field sales motion. The company employs 11-50 staff and does not publicly disclose revenue, funding, or customer counts. Distribution is direct, supplemented by a web-based customer fulfillment portal for ordering, inventory, and shipment tracking.

LaunchWorks firmographics

Firmographics
Name
LaunchWorks
Legal name
LaunchWorks, LLC
Website
https://launchworkscdmo.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
LaunchWorks CDMO is an ISO-13485:2016 certified, FDA-registered contract development and manufacturing organization specializing in molecular diagnostics. It serves diagnostic startups and commercial-scale life science companies with design, formulation, fill/finish, lyophilization, and cold-chain fulfillment services.
Ownership category
akta.pro rank

LaunchWorks industry classification

Industry
Product category
Contract Manufacturing (CDMO for Molecular Diagnostics)
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro primary industry
Lyophilization (Freeze-Drying) CDMO (HLAGABAI)

Keywords

  • Contract manufacturing services
  • Molecular diagnostics manufacturing
  • Life sciences CDMO
  • Lyophilization services
  • Diagnostic kit assembly

Where LaunchWorks is headquartered

Location

Headquarters

HQ city
Beverly
HQ country
United States
HQ region
North America

Offices3 records

Markets served

LaunchWorks business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: Full-service CDMO providing molecular diagnostics manufacturing including formulation, filling, labeling, kit assembly, and quality control testing under cGMP and ISO 13485 standards. Revenue generated through project-based contracts with dedicated project management.
  2. Design and Development Services: Product development services including raw material optimization, guard banding studies, pilot lot builds, final package and label design, and stability studies. Provided as part of the CDMO service offering.
  3. Fulfillment and Storage Services: Order management, inventory management, kitting services, product tracking, carrier logistics, and temperature-controlled storage (+4°C, -20°C, -80°C) for finished diagnostic products.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

LaunchWorks product offering

Product offering

Core offering

LaunchWorks CDMO provides full-service contract development and manufacturing for molecular diagnostics and life science products, spanning design and development, technology transfer, cGMP/ISO-13485 manufacturing (formulation, automated and manual filling, lyophilization, kit assembly, labeling), quality control testing, and temperature-controlled fulfillment and storage. Its offerings are organized around a proprietary five-phase Product Manufacturing Plan that takes RUO, POC, and IVD products from pilot lot through commercial launch and post-launch optimization.

Product overview

LaunchWorks CDMO is a full-service Contract Development and Manufacturing Organization (CDMO) specializing in molecular diagnostics manufacturing. The company offers an integrated suite of services organized around its proprietary five-stage Product Manufacturing Plan: Design & Development (including lyophilization, stability testing, and QC specification development), Technology Transfer & Onboarding, Precision Manufacturing (formulation, filling, labeling, kitting), Product Launch & Fulfillment (including cold-chain logistics and storage), and Post-Launch Efficiencies. Key product types include dry chemistry sample collection kits, complex NGS kits containing hundreds of oligonucleotides, and custom enzyme purification services. The company is ISO-13485:2016 certified and FDA registered, serving startup innovators through high-volume commercial manufacturers in the RUO, POC, and IVD segments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Design & Development Services

Quantifiable outcome

  • Reduced time to market through integrated design, development, and manufacturing services
  • +2 more outcomes

Companies that use LaunchWorks

Customer profile

Segments5 records

Ideal customer profiles4 records

LaunchWorks technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

LaunchWorks partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • Integreon Global (Parent Company)coreOthers · 1 January 2019Integreon Global acquired LaunchWorks in 2017. The parent company provides business relationships for lyophilization, precision plastic molding, and cold chain packing solutions. LaunchWorks rebranded from LaunchWorks Manufacturing Lab to LaunchWorks CDMO as part of the Integreon Global family of companies.
  • Cryopak Canada (Sister Company)coreStrategic or Co-development Partner · 1 January 2019LaunchWorks Manufacturing Lab and Cryopak Canada collaborated with NRC to create LIFT (Laboratory of Industrial Fluidic Translation). Cryopak provides cold chain packaging solutions and together they established an MDEL licensed clean room lab facility in Montreal for CDMO projects.
  • Laboratory of Industrial Fluidic Translation (LIFT)coreStrategic or Co-development Partner · 1 January 2019Joint collaboration between LaunchWorks, Cryopak Canada, and NRC to offer competitive capacity for microfluidic bio-device development. Design and development done at NRC in Montréal with manufacturing at LaunchWorks Beverly facility and future plans for additional manufacturing at Cryopak Canada.
  • National Research Council of Canada (NRC)coreStrategic or Co-development PartnerNRC partners with Canadian industry to take research impacts from the lab to the marketplace. The NRC-LIFT collaboration combines NRC's expertise in nanofabrication and lab-on-a-chip technologies with LaunchWorks' cGMP and ISO 13485 manufacturing capabilities at clinical and industrial scale to accelerate creation, certification and deployment of microfluidic bio-devices.
  • Mercury LogisticscoreChannel Partner/ Reseller/ DistributorOfficial LaunchWorks logistics partner specializing in time and temperature sensitive supply chain management. Creates customized shipping solutions and proactively tracks every package to ensure products reach destinations safely.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

LaunchWorks competitors and assessment

Company assessment

Direct peers

  • GenScript: Global biotechnology CDMO offering gene synthesis, protein production, and custom reagent manufacturing with diagnostics industry focus. Comparable service portfolio including custom oligonucleotides, peptide synthesis, and diagnostic kit assembly.
  • Curia (formerly AMRI): Contract development and manufacturing organization offering integrated services from drug discovery through commercial manufacturing. Similar CDMO business model to LaunchWorks, with comparable services in formulation, filling, and analytical testing, though broader therapeutic focus.
  • Meridian Bioscience: Diagnostics-focused manufacturer of IVD test kits and reagents, including molecular diagnostics. Now part of Revvity/Sumitomo. Directly comparable to LaunchWorks in serving the molecular diagnostics manufacturing market with similar customer profiles of diagnostic developers and clinical labs.
  • Bio-Techne: Manufacturer of reagents and diagnostic test kits for life sciences research and clinical diagnostics. Similar focus on molecular biology reagents, qPCR, and protein analysis. Overlapping customer segments of academic, biotech, and diagnostic companies requiring specialized reagent manufacturing.
  • FUJIFILM Irvine Scientific: CDMO specializing in cell culture media, diagnostics reagents, and life sciences manufacturing. Comparable in serving diagnostic and biotech customers with custom manufacturing services, though focused on cell-based applications rather than purely molecular diagnostics.
  • Aldevron: CDMO specializing in nucleic acids, proteins, and biological components for diagnostic and therapeutic applications. Now part of Danaher. Direct peer in serving molecular diagnostics customers with custom manufacturing of complex biological reagents, similar to LaunchWorks' NGS kit and enzyme purification services.

Broad incumbents

  • Bio-Rad Laboratories: Major life sciences and diagnostics company with significant molecular diagnostics manufacturing capabilities, including digital PCR and qPCR products. Broader portfolio and global footprint than LaunchWorks, but overlapping customer base in IVD kit manufacturing and contract services.
  • Eurofins Genomics: Part of Eurofins Scientific network, offering genomics services and custom oligo/kit manufacturing. Direct overlap in custom NGS kit manufacturing and oligonucleotide services. Significantly larger scale and broader geographic footprint than LaunchWorks.
  • Thermo Fisher Scientific (CDMO Services): Global leader in life sciences with substantial CDMO capabilities through its Pharma Services division. Direct overlap in diagnostic kit manufacturing, custom reagent production, and analytical services. Significantly larger scale and resources than LaunchWorks.
  • LGC Group (including SeraCare): Life sciences measurement and testing company with diagnostics manufacturing capabilities through SeraCare (now LGC Clinical Diagnostics). Provides reference materials, controls, and custom IVD manufacturing comparable to LaunchWorks' QC testing and diagnostic kit production services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

LaunchWorks compliance and trust

Trust signal

Compliance3 records

LaunchWorks financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LaunchWorks leadership team

Management profile

Number of profiles

Profiles4 records

LaunchWorks funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LaunchWorks M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LaunchWorks

What does LaunchWorks do?

LaunchWorks CDMO provides full-service contract development and manufacturing for molecular diagnostics and life science products, spanning design and development, technology transfer, cGMP/ISO-13485 manufacturing (formulation, automated and manual filling, lyophilization, kit assembly, labeling), quality control testing, and temperature-controlled fulfillment and storage. Its offerings are organized around a proprietary five-phase Product Manufacturing Plan that takes RUO, POC, and IVD products from pilot lot through commercial launch and post-launch optimization.

Is LaunchWorks a public or private company?

LaunchWorks is a private company. It is classified as corporate owned and is currently operating.

When was LaunchWorks founded?

LaunchWorks was founded in 2010. It employs 11 to 50 people.

Where is LaunchWorks based?

LaunchWorks is headquartered in Beverly, United States, in the North America region.

How does LaunchWorks make money?

Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are design and Development Services and fulfillment and Storage Services.

Who are LaunchWorks's main competitors?

Direct peers on record are GenScript, Curia (formerly AMRI), Meridian Bioscience, Bio-Techne, FUJIFILM Irvine Scientific and Aldevron. Broad incumbents are Bio-Rad Laboratories, Eurofins Genomics, Thermo Fisher Scientific (CDMO Services) and LGC Group (including SeraCare).

Does LaunchWorks have an API?

No public API is recorded for LaunchWorks.

What industry is LaunchWorks in?

LaunchWorks's product category is Contract Manufacturing (CDMO for Molecular Diagnostics). Its primary akta.pro industry code is HLAGABAI, Lyophilization (Freeze-Drying) CDMO. Its NAICS code is 325413 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LaunchworkscdmoRegulatory Compliance: What You Need to Know About ISO 13485An explainer article describes ISO 13485, the International Organization for Standardization's quality management system standard for medical device manufacturers, including In-Vitro Diagnostics, and the third-party audits required for certification. It states that certification is generally accepted worldwide and that longer certification tenure indicates a more mature quality system. The piece promotes LaunchWorks as an ISO 13485 certified, FDA-registered CDMO.GlobeNewswireLaunchWorks and Canadienzyme Collaboration Results in New Product for Diagnostic TestingLaunchWorks and Canadienzyme announced a collaboration to produce a new RT-qPCR Master Mix for diagnostic testing. The made-in-Canada reagent works as well as international versions and is now available in the US and Canada. The companies will continue exploring other diagnostic products.GlobeNewswireLaunchWorks Scales up its Diagnostic Test Kit Manufacturing CapabilitiesLaunchWorks added new automation equipment at its Beverly, MA and Anjou, Canada facilities to increase diagnostic test kit filling capacity. The expansion enables production of up to 500,000 microtubes or transport media tubes per week, with improved reproducibility and redeployable machines.GlobeNewswireLaunchWorks Opens New Facility in Anjou CanadaLaunchWorks opened a new facility in Anjou, Quebec, to support its diagnostics manufacturing. The facility is FDA-registered and holds a Medical Device Establishment License from Health Canada, with ISO 13485 compliance. The company plans to expand its U.S. and Canadian product offerings.GlobeNewswireLexaGene Engages Contract Manufacturer to Support Product LaunchLexaGene Holdings engaged LaunchWorks to manufacture consumables for its MiQLab rapid pathogen detection system, with production expected to support the commercial launch by September 2020. The company expects to begin selling and fulfilling delivery of first units by the end of next month.